Systemic inflammation score predicts survival in patients with intrahepatic cholangiocarcinoma undergoing curative resection

In conclusions, our findings demonstrate that the SIS as a potentially powerful prognostic biomarker in ICC that predicts poor clinical outcomes and is a promising tool for ICC treatment strategy decisions.

Source: Journal of Cancer - June 13, 2019 Category: Cancer & Oncology Authors: Yong Zhang, Shi-Ming Shi, Hua Yang, Liu-Xiao Yang, Zheng Wang, Xue-Dong Li, Dan Yin, Ying-Hong Shi, Ya Cao, Zhi Dai, Jian Zhou, Qing Chen Tags: Research Paper Source Type: research